[Ip-health] The Medicines Patent Pool Newsletter 0: 11 May 2011

Kaitlin Mara kmara at medicinespatentpool.org
Thu May 12 05:37:47 PDT 2011

[Please disregard the previous email—all the links work in this one]

Medicines Patent Pool Newsletter 0: 11 May, 2011

The Medicines Patent Pool is working to make affordable, appropriate HIV
medicines available to those that need them in developing countries by
negotiating licences from medicines patent holders such as drug companies
and research institutes. This exciting new project, founded with the
support of financing mechanism UNITAID, aims to bring down the prices of
HIV drugs and encourage the development of desperately needed new
treatments - like formulations for children.

To get all the latest news from the Pool, subscribe to the newsletter by
clicking here:

Having trouble viewing this email? Click here to read it in your browser:

Pool in formal negotiations with 5 patent holders

The Medicines Patent Pool is now undergoing formal negotiations with
Gilead, Roche, Sequoia Pharmaceuticals, Viiv Healthcare (a joint venture
of GlaxoSmithKline and Pfizer) and the US National Institutes of Health.
These negotiations cover nine critical antiretroviral medicines listed
among the Pool's nineteen target drugs, as well as several other medicines
needed for the treatment of HIV in developing countries.

The Pool has also been in dialogue with Tibotec/Johnson & Johnson and
Bristol-Myers Squibb and hopes that these companies soon decide to come to
the negotiating table as well.

For regular updates on the Pool's negotiating status, see our website
here: http://www.medicinespatentpool.org/LICENSING/Company-Engagement.

Pool at upcoming events at the World Health Assembly and WIPO

The Pool's Executive Director Ellen 't Hoen will be speaking at an event
on the occasion of the World Health Organization's annual decision-making
World Health Assembly.

Hosted by UNITAID, the technical briefing on "Healthy markets for healthy
people in developing countries" will take place on 18 May from 18:00-20:00
in the Palais des Nations Room VIII, Geneva. To register for the side
event, contact Ms Fabienne Maertens at maertensf at who.int<mailto:maertensf at who.int>.

The Standing Committee on the Law of Patents (SCP) is WIPO's forum for the
discussion of international patent laws and norms. The Medicines Patent
Pool will host an event on the occasion of the SCP that will bring
together key public health and intellectual property stakeholders for a
technical briefing on how the Pool can best be of assistance in addressing
the HIV crises for affected member states. The briefing will take place on
18 May, from 13:00 to 15:00 in the WIPO building in Geneva, Switzerland.

For more information on this event see the Medicines Patent Pool website
side-event <http://www.medicinespatentpool.org/>.

To get all the latest news from the Pool, join our newsletter by clicking

Pool launches most complete source of open access patent information on
HIV medicine

On 4 April, the Pool launched a patent status database for select HIV
medicines. A critical resource for public health professionals, the patent
status database is the most comprehensive source of publicly-available
information on key HIV-related intellectual property in the world. It can
be accessed here:

Developed with the cooperation of WIPO, it will help shed light on where
key patents exist for antiretroviral drugs for the treatment of HIV in
developing countries. ³Reliable patent status information is often hard to
come by, though it is essential to our work in negotiating licences. After
compiling this information with the aid of WIPO, it was a logical next
step to put it in the public domain where it can be used and improved upon
by others,² said Ellen Œt Hoen, executive director of the Pool at the
databases' launch. For more on the launch of this new tool, see the Pool's
website here:

Pool welcomes new team member

The Medicines Patent Pool is pleased to welcome Sandeep Juneja to its team
as the new Business Development Director. Sandeep comes to the Pool after
more than 15 years of experience in the pharmaceutical industry, including
6 years as the director of global business on HIV & Malaria at Ranbaxy in
New Delhi, India.

To get all the latest news from the Pool,join our newsletter by clicking
here http://www.medicinespatentpool.org/newsletter/register_subscription/1.
The Medicines Patent Pool newsletter provides periodic updates on news
from and pertaining to the Pool. To receive these updates, click here to
sign up
To unsubscribe at any time, send an email to
office at medicinespatentpool.org<mailto:office at medicinespatentpool.org> with the words ³No Updates² in the subject

More information about the Ip-health mailing list